| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Dimethyl fumarate |
| Brand | Skilarence® |
| Indication | For the treatment of moderate to severe plaque psoriasis in adults in need of systemic medicinal therapy. |
| Assessment Process | |
| Rapid review commissioned | 15/01/2018 |
| Rapid review completed | 06/02/2018 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Recommended |
The HSE has approved reimbursement following a price negotiation February 2019.